创新医疗今日涨停，全天换手率25.23%，成交额16.37亿元，振幅10.03%。龙虎榜数据显示，机构净买 入5091.67万元，营业部席位合计净买入1.49亿元。 资金流向方面，今日该股主力资金净流入4.72亿元，其中，特大单净流入4.81亿元，大单资金净流出 890.01万元。近5日主力资金净流入4.32亿元。（数据宝） 创新医疗8月5日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 国泰海通证券股份有限公司成都北一环路证券营业部 | 7365.83 | 10.03 | | 买二 | 机构专用 | 6804.36 | 3964.80 | | 买三 | 国信证券股份有限公司北京分公司 | 5434.44 | 190.45 | | 买四 | 国泰海通证券股份有限公司上海松江区中山东路证券营 业部 | 4874.94 | 23.59 | | 买五 | 机构专用 | 3494.39 | 1242.28 | | 卖一 | 机构专用 | 6804.36 | 3964.80 | | ...

Market Overview - On August 5, the Shanghai Composite Index rose by 0.96%, the Shenzhen Component Index increased by 0.59%, the ChiNext Index went up by 0.39%, and the CSI 300 Index gained 0.80% [1] - Among the tradable A-shares, 3,903 stocks rose, accounting for 72.17%, while 1,327 stocks declined [1] Capital Flow - The main capital saw a net outflow of 11.676 billion yuan throughout the day [1] - The ChiNext experienced a net outflow of 6.731 billion yuan, while the STAR Market had a net outflow of 1.542 billion yuan [1] - The CSI 300 constituent stocks saw a net inflow of 2.692 billion yuan [1] Industry Performance - Out of the 31 first-level industries classified by Shenwan, the top-performing sectors were Comprehensive and Banking, with increases of 1.98% and 1.59% respectively [1] - The Communication industry led the net inflow of main capital, with a net inflow of 2.485 billion yuan and a daily increase of 1.25% [1] - The Non-bank Financial sector followed with a daily increase of 1.23% and a net inflow of 1.567 billion yuan [1] Industry Capital Outflow - The Pharmaceutical and Biological industry had the largest net outflow, with a net outflow of 5.336 billion yuan despite a daily increase of 0.12% [1] - The Computer industry also saw significant outflow, with a net outflow of 3.102 billion yuan and a daily increase of 0.25% [1] - Other industries with notable net outflows included Defense and Military, Machinery Equipment, and Electronics [1] Individual Stock Performance - A total of 1,999 stocks experienced net inflows, with 742 stocks having net inflows exceeding 10 million yuan [2] - Among these, 83 stocks had net inflows exceeding 100 million yuan, with Dongxin HePing leading at a net inflow of 570 million yuan and a daily increase of 10.00% [2] - The stocks with the largest net outflows included Shanhe Intelligent, Hanyu Pharmaceutical, and Aerospace Electronics, with net outflows of 910 million yuan, 909 million yuan, and 588 million yuan respectively [2]

Market Performance - The brain-computer interface concept rose by 2.72%, ranking third among concept sectors, with 27 stocks increasing in value [1][2] - Notable gainers included Innovation Medical, ST Huaton, and Aipeng Medical, which surged by 13.97%, 7.52%, and 7.40% respectively [1][2] Capital Flow - The brain-computer interface sector saw a net inflow of 679 million yuan, with 21 stocks receiving net inflows, and 6 stocks exceeding 30 million yuan in net inflow [2][3] - Innovation Medical led the net inflow with 472 million yuan, followed by ST Huaton and Aipeng Medical with 146 million yuan and 55 million yuan respectively [2][3] Stock Performance - The top stocks by net inflow ratio included Innovation Medical at 28.82%, followed by Jiahe Intelligent at 9.74% and Entropy Technology at 8.96% [3] - Other notable performers included ST Huaton with a 5.03% increase and Aipeng Medical with a 7.52% increase [4]

Group 1 - The high-pressure oxygen chamber concept increased by 1.76%, ranking 7th among concept sectors, with 7 stocks rising, including Innovation Medical which hit the daily limit, and others like Beiyikang and Weiao Shares rising by 7.40%, 2.86%, and 0.74% respectively [1][2] - The concept sector saw a net inflow of 262 million yuan, with Innovation Medical receiving the highest net inflow of 472 million yuan, followed by Weiao Shares and Yingkang Life with net inflows of 3.37 million yuan and 769,200 yuan respectively [2][3] - The main capital inflow ratios for Innovation Medical, Weiao Shares, and Yingkang Life were 28.82%, 4.53%, and 0.85% respectively, indicating strong investor interest in these stocks [3] Group 2 - The top gainers in the high-pressure oxygen chamber concept included Innovation Medical with a daily increase of 10.03% and a turnover rate of 25.23%, while other stocks like Weiao Shares and Yingkang Life had increases of 2.86% and 0.68% respectively [3] - Conversely, stocks such as Tiedian Heavy Industry, Samsung Medical, and Jinling Pharmaceutical experienced declines of 1.50%, 0.70%, and 0.41% respectively, indicating a mixed performance within the sector [1][4]

证券之星消息，8月5日医疗服务板块较上一交易日上涨0.57%，创新医疗领涨。当日上证指数报收于 3617.6，上涨0.96%。深证成指报收于11106.96，上涨0.59%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002173 | 创新医疗 | 16.23 | 10.03% | 105.03万 | | 16.37亿 | | 688046 | 药康生物 | 17.24 | 5.06% | 8.90万 | | 1.54亿 | | 000504 | *ST生物 | 11.44 | 4.38% | 8.64万 | | 9815.92万 | | 301333 | 诺思格 | 57.77 | 3.87% | - 4.66万 | | 2.68亿 | | 301293 | 三博脑科 | 51.63 | 3.84% | 16.56万 | | 8.45亿 | | 301096 | 百诚医药 | 61.19 | 3.29% | 9.14万 | | 5.55亿 | ...

Core Insights - Huawei's Ascend concept saw a 0.7% increase on August 5, with a net inflow of 104 million yuan in main funds, indicating positive market sentiment towards the concept [1] - Among the 34 concept stocks, 21 experienced price increases while 13 saw declines, reflecting a mixed performance in the sector [1] Fund Inflow Summary - The top net inflows were led by Innovation Medical with 465 million yuan, followed by Changshan Beiming with 90.38 million yuan, and Runhe Software with 62.51 million yuan [1] - The net inflow percentages for the leading stocks were 28.4% for Innovation Medical, 5.31% for Changshan Beiming, and 4.11% for Runhe Software, indicating strong investor interest in these companies [1] Stock Performance Overview - Innovation Medical's latest price was 16.23 yuan with a 10.03% increase, while Changshan Beiming was priced at 23.43 yuan with a 1.69% rise [1] - Other notable performers included Dongfang Guoxin with a 1.92% increase and Guangha Communication with a 4.49% rise, showcasing a generally positive trend among selected stocks [1]

Group 1 - A-shares experienced significant activity on August 5, with 68 stocks hitting the daily limit up and 2 stocks hitting the limit down [1] - The human brain engineering concept saw active trading, with Innovation Medical reaching the limit up [1] - The PEEK materials concept strengthened, leading to limit up performances for Zhongxin Fluorine Materials and Xinhan New Materials [1] Group 2 - *ST Yuancheng and Honghe Technology both hit the limit down [2]

格隆汇8月5日｜A股市场脑机接口概念股走强，其中，翔宇医疗涨近12%，创新医疗涨超6%，普利特、 爱朋医疗涨超5%，泰和科技涨超4%，熵基科技涨超3%。 ...

2025年1月-3月，创新医疗实现营业收入1.93亿元，同比减少3.98%；归属净利润-1393.74万元，同比减 少368.03%。 来源：金融界 8月5日，创新医疗盘中10.03%涨停，截至14:00，报16.23元/股，成交13.67亿元，换手率21.23%，总市 值71.62亿元。 资料显示，创新医疗管理股份有限公司位于浙江省诸暨市山下湖镇郑家湖村，公司的主营业务是提供医 疗服务，旗下包括建华医院、康华医院、福恬医院和明珠医院四家医疗机构，致力于满足患者需求和提 高医疗质量。公司通过精细化管理，科室建设，人才引培等方式以提升核心竞争力，同时关注行业政 策，进行供应链整合，以优化医疗资源和提高治疗效果。 截至3月31日，创新医疗股东户数6.82万，人均流通股6108股。 ...

创新医疗主要涉及脑机接口、医疗服务、医疗器械、人工智能医疗等概念板块。 注：本内容由算法自动生成，不构成投资建议。 根据异动分析，可能的影响因素如下： 国家医保局制定新上市药品首发价格机制，新增"脑机接口置入费""脑机接口适配费"等价格项目，脑机 接口技术成熟获批进入临床后可快速进入临床应用并收费；创新医疗为国内首个植入式脑机接口多中心 临床试验（2024年6月获批，针对高位截瘫）持有者，拥有Ⅲ类医疗器械注册证（癫痫干预系统），落 地场景包括天坛医院临床治疗、泰康养老社区监护。 截至14时0分，创新医疗涨幅为10.03%，最新价16.23元，总市值71.62亿元，封板资金11.88亿元，成交 额13.86亿元，换手率21.52%，所属行业为医疗服务。 ...